Patent ID: 8193175

Claim:
A pharmaceutical composition comprising, in a pharmaceutically acceptable support, at least one complex ruthenium compound (II) with the following general formula (I) or (II): formula (I) or (II) in which: L 1 , L 2 , L 3 and L 4 , identical or different, represent a donor ligand with 2 electrons to one nitrogen, oxygen, phosphorus or sulphur atom, R1 represents a hydrogen atom or one or more substitutions on the phenyl group, chosen from a (C1-6)alkyl and (C6-18)aryl radical, Y is a counter-ion (when m =1), m is 0 or 1, between C and N, represented by a curved line, there is a series of atoms forming, with the carbon, nitrogen and ruthenium atoms shown in formulae (I) and (II), the metallocycle, which is formed by between 5 and 8 atoms (including the carbon, nitrogen and ruthenium atoms shown in formulae (I) and (II)), wherein the atoms of the series of atoms are selected from the group consisting of carbon, nitrogen, oxygen and sulphur atoms.